EUVIMEDEUVIMED entdecken
Crossref

Bromelain Alleviates 3‐Nitropropionic Acid‐Induced Huntington's Disease‐Like Symptoms in Rats Through the Interplay of SIRT1 / PGC ‐1α and FOXO3a Pathways

Omnia M Nady, Salma E Said iD, Sherehan M Ibrahim, Maheera H Safwat iD

BioFactors · 2025

DOI: 10.1002/biof.70054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2025. Verfasst von Omnia M Nady und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Huntington Disease, Sirtuin 1, Forkhead Box Protein O3, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bromelain, a combination of pineapple‐derived enzymes, has demonstrated neuroprotective effects owing to its antioxidant and anti‐inflammatory attributes. The current study intended to explore bromelain's neuroprotective impact against 3‐nitropropionic acid (3‐NP)‐induced Huntington's disease (HD)‐like symptoms in rats. Four groups of rats were randomly allocated: group 1 received saline; bromelain (40 mg/kg/i.p.) was given to groups 2 and 4 daily, whereas groups 3 and 4 received daily doses of 3‐NP (10 mg/kg/i.p.) for 14 days. On the molecular level, bromelain administration resulted in upregulation of striatal SIRT‐1, PGC‐1α, TFAM and Nrf2 expression, enhancement of Akt phosphorylation, elevation of FOXO3a deacetylation and lessening of striatal oxidative stress damage by lowering MDA concentrations as well as raising the levels of NQO1, TAC, SOD and GSH. These effects were further substantiated by improvements in muscle strength, locomotor coordination, cognitive performance, and neuronal integrity. In conclusion, bromelain could be a beneficial neuroprotective candidate against HD‐like aberrations experimentally induced by 3‐NP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseSirtuin 1Forkhead Box Protein O3Neuroprotective AgentsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaBromelainsAnimalsNitro CompoundsPropionatesRatsMaleOxidative StressSignal TransductionDisease Models, AnimalAntioxidantsRats, Wistar

Stichwörter der Autor:innen

PGC‐1α/Nrf2SIRT1/FOXO3a3‐nitropropionic acidbromelainmitochondrial biogenesisneuronal survival

Substanzen

3-nitropropionic acidNitro CompoundsPropionatesSirtuin 1Forkhead Box Protein O3Neuroprotective AgentsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaBromelainsPpargc1a protein, ratSirt1 protein, rat

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.

ORCID-Profile: Salma E Said, Maheera H Safwat

Zitieren

APA

Nady, O. M., Said, S. E., Ibrahim, S. M., & Safwat, M. H. (2025). Bromelain Alleviates 3‐Nitropropionic Acid‐Induced Huntington's Disease‐Like Symptoms in Rats Through the Interplay of SIRT1 / PGC ‐1α and FOXO3a Pathways. BioFactors. https://doi.org/10.1002/biof.70054

Vancouver

Nady OM, Said SE, Ibrahim SM, Safwat MH. Bromelain Alleviates 3‐Nitropropionic Acid‐Induced Huntington's Disease‐Like Symptoms in Rats Through the Interplay of SIRT1 / PGC ‐1α and FOXO3a Pathways. BioFactors. 2025. doi:10.1002/biof.70054

BibTeX
@article{Nady2025,
  author = {Nady, Omnia M and Said, Salma E and Ibrahim, Sherehan M and Safwat, Maheera H},
  title = {Bromelain Alleviates 3‐Nitropropionic Acid‐Induced Huntington's Disease‐Like Symptoms in Rats Through the Interplay of SIRT1 / PGC ‐1α and FOXO3a Pathways},
  journal = {BioFactors},
  year = {2025},
  doi = {10.1002/biof.70054}
}
Kostenlos starten →